Neurocrine Bioscienc (NBIX): Congress and insider trades
Who in Congress and inside the company traded NBIX, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Neurocrine Bioscienc (NBIX) is a listed stock on NASDAQ.
- 3 members of Congress filed 11 buys and 16 sells of NBIX, the latest published 2023-11-20 (20 November 2023).
- Insiders filed 0 open market buys worth $0 and 17 sells worth $60M, the latest filed 2026-09-10 (10 September 2026).
- Across 5 scored buys, Congress averaged -9.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 40% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in NBIX
as of 2023-11-20| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 20 Nov 2023 | Michael McCaul (R-TX) | sell | 15K–50K | 21 | n/a |
| 20 Nov 2023 | Michael McCaul (R-TX) | sell | 50K–100K | 21 | n/a |
| 25 Sep 2023 | Michael McCaul (R-TX) | buy | 50K–100K | 37 | +0.4% |
| 25 Sep 2023 | Michael McCaul (R-TX) | buy | 15K–50K | 37 | +0.4% |
| 23 Jun 2023 | Michael McCaul (R-TX) | sell | 15K–50K | 51 | n/a |
| 23 Jun 2023 | Michael McCaul (R-TX) | sell | 15K–50K | 51 | n/a |
| 10 Mar 2023 | Ro Khanna (D-CA) | sell | 1K–15K | 26 | n/a |
| 21 Jan 2023 | Michael McCaul (R-TX) | sell | 1K–15K | 35 | n/a |
| 21 Jan 2023 | Michael McCaul (R-TX) | sell | 1K–15K | 35 | n/a |
| 4 Jan 2023 | Ro Khanna (D-CA) | buy | 1K–15K | 28 | -24.7% |
| 24 Feb 2022 | Michael McCaul (R-TX) | sell | 1K–15K | 26 | n/a |
| 24 Feb 2022 | Michael McCaul (R-TX) | sell | 1K–15K | 26 | n/a |
| 28 Jan 2022 | Michael McCaul (R-TX) | sell | 15K–50K | 37 | n/a |
| 28 Jan 2022 | Michael McCaul (R-TX) | sell | 1K–15K | 44 | n/a |
| 28 Jan 2022 | Michael McCaul (R-TX) | sell | 15K–50K | 37 | n/a |
| 28 Jan 2022 | Michael McCaul (R-TX) | sell | 1K–15K | 44 | n/a |
| 16 Sep 2021 | Ro Khanna (D-CA) | sell | 1K–15K | 29 | n/a |
| 17 Jul 2021 | Michael McCaul (R-TX) | buy | 15K–50K | 22 | +6.3% |
| 17 Jul 2021 | Michael McCaul (R-TX) | buy | 15K–50K | 22 | +6.3% |
| 20 Apr 2021 | Michael McCaul (R-TX) | buy | 15K–50K | 41 | -5.5% |
| 20 Apr 2021 | Michael McCaul (R-TX) | buy | 15K–50K | 41 | -5.5% |
| 12 Jan 2021 | Gil Cisneros (D-CA) | buy | 1K–15K | 21 | -23.1% |
| 17 Dec 2020 | Ro Khanna (D-CA) | buy | 1K–15K | 43 | n/a |
| 15 Dec 2020 | Michael McCaul (R-TX) | buy | 50K–100K | 32 | n/a |
| 15 Dec 2020 | Michael McCaul (R-TX) | buy | 50K–100K | 32 | n/a |
| 1 Dec 2020 | Michael McCaul (R-TX) | sell | 50K–100K | 60 | n/a |
| 1 Dec 2020 | Michael McCaul (R-TX) | sell | 50K–100K | 60 | n/a |
Nothing matches that search.
Insider trades in NBIX
as of 2026-09-10| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 10 Sep 2026 | BENEVICH ERIC | sell | 2,154 | $154.61 | $333K | n/a |
| 30 Jul 2026 | Norwalk Leslie V | sell | 1,250 | $182.01 | $228K | n/a |
| 13 Jul 2026 | Lippoldt Darin | sell | 10,000 | $179.60 | $1.8M | n/a |
| 13 Jul 2026 | Delaet Ingrid | sell | 4,367 | $181.02 | $791K | n/a |
| 9 Jul 2026 | Delaet Ingrid | sell | 8,433 | $178.72 | $1.5M | n/a |
| 9 Jul 2026 | Delaet Ingrid | sell | 2,737 | $178.54 | $489K | n/a |
| 9 Jul 2026 | Delaet Ingrid | sell | 3,401 | $178.57 | $607K | n/a |
| 30 Jun 2026 | Lippoldt Darin | sell | 200 | $169.56 | $33.9K | n/a |
| 30 Jun 2026 | Lippoldt Darin | sell | 9,800 | $170.16 | $1.7M | n/a |
| 9 Jun 2026 | SHERWIN STEPHEN A | sell | 25,000 | $165.32 | $4.1M | n/a |
| 8 Jun 2026 | Norwalk Leslie V | sell | 1,250 | $168.06 | $210K | n/a |
| 4 Jun 2026 | Cooke Julie | sell | 36,937 | $156.22 | $5.8M | n/a |
| 2 Jun 2026 | Delaet Ingrid | sell | 2,261 | $156.71 | $354K | n/a |
| 2 Jun 2026 | Onyia Jude | sell | 11,000 | $160.25 | $1.8M | n/a |
| 29 May 2026 | Onyia Jude | sell | 11,000 | $155.53 | $1.7M | n/a |
| 28 May 2026 | Boyer David W. | sell | 3,888 | $156.64 | $609K | n/a |
| 21 May 2026 | GORMAN KEVIN CHARLES | sell | 245,088 | $154.33 | $38M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought NBIX?
11 Congress buys by 3 members and 0 insider buys are on file. The tables on this page list every one.
Did buying NBIX after a disclosure beat the market?
Across 5 scored buys, Congress averaged -9.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 40% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.